About Codiak

Codiak, founded in 2015, is the leader in the rapidly developing field of exosome biology. The company was formed on the basis of research from the VentureLabs innovation unit of Flagship Ventures; the research of Jan Lotvall, M.D. Ph.D., Chairman of the Krefting Research Centre at University of Gothenburg, Sweden; and from the seminal work of Dr. Raghu Kalluri at The University of Texas MD Anderson Cancer Center in Houston, TX.

 

Codiak was founded by an investor syndicate led by ARCH Venture Partners and Flagship Ventures, with participation by Fidelity Management and Research Company, the Alaska Permanent Fund and Alexandria Venture Investments.

Learn more about the power of exosomes.